Irritable bowel syndrome pathophysiology: Difference between revisions
| Line 41: | Line 41: | ||
*'''CNS dysregulation'''- The conceptualization of IBS being a brain gut disorder is reinforced by the following- | *'''CNS dysregulation'''- The conceptualization of IBS being a brain gut disorder is reinforced by the following- | ||
1) Epidemiological studies that suggest that it occurs in individuals who have experienced childhood trauma with symptom exacerbation occurring in patients with emotional disturbances or stress. Traumatic experiences before the age of 18 can directly shape adult connectivity in the executive control network. The effects on structures such as the insula, anterior cingulate cortex and the thalamus have been implicated in the pathophysiology of central pain amplification. IBS has been found to have a high association with pre-existing psychiatric and psychological conditions like anxiety and depression. However, studies have shown that even when patients are not anxious or depressed, the dorsolateral prefrontal cortex activity was reduced, suggesting CNS dysfunction and increased susceptibility to stressors. | 1) Epidemiological studies that suggest that it occurs in individuals who have experienced childhood trauma with symptom exacerbation occurring in patients with emotional disturbances or stress. Traumatic experiences before the age of 18 can directly shape adult connectivity in the executive control network. The effects on structures such as the insula, anterior cingulate cortex and the thalamus have been implicated in the pathophysiology of central pain amplification. IBS has been found to have a high association with pre-existing psychiatric and psychological conditions like anxiety and depression. However, studies have shown that even when patients are not anxious or depressed, the dorsolateral prefrontal cortex activity was reduced, suggesting CNS dysfunction and increased susceptibility to stressors. | ||
2) Psychological therapies that act on cerebral cortical sites and antidepressants have proven to be one of the mainstays of therapy for patients. For example, the fact that probiotics can modify signal processing in the brain also supports this theory. | 2) Psychological therapies that act on cerebral cortical sites and antidepressants have proven to be one of the mainstays of therapy for patients. For example, the fact that probiotics can modify signal processing in the brain also supports this theory. | ||
3) Studies using advanced brain imaging techniques have analysed differences in brain activity between patients and healthy controls and have helped us appreciate that the mid-cingulate cortex- responsible for attention processes and responses and the prefrontal cortex-responsible for vigilance and alertness of the human brain could be involved in IBS. Modulation of the mid-cingulate cortex is associated with alterations in the subjective sensations of pain whereas prefrontal cortex modulation may lead to increased perception of visceral pain. Patients with IBS have been found to have aberrant processing of central information, with decreased feedback on the emotional arousal network that controls the autonomic modulation of gastrointenstinal function. These have been seen as irregularities on diffusion tensor imaging in the white matter of the brain. Rectal balloon distension in patients have shown increased involvement of regions of the brain associated with attentional and behavioural responses to the arrival of such stimuli. | 3) Studies using advanced brain imaging techniques have analysed differences in brain activity between patients and healthy controls and have helped us appreciate that the mid-cingulate cortex- responsible for attention processes and responses and the prefrontal cortex-responsible for vigilance and alertness of the human brain could be involved in IBS. Modulation of the mid-cingulate cortex is associated with alterations in the subjective sensations of pain whereas prefrontal cortex modulation may lead to increased perception of visceral pain. Patients with IBS have been found to have aberrant processing of central information, with decreased feedback on the emotional arousal network that controls the autonomic modulation of gastrointenstinal function. These have been seen as irregularities on diffusion tensor imaging in the white matter of the brain. Rectal balloon distension in patients have shown increased involvement of regions of the brain associated with attentional and behavioural responses to the arrival of such stimuli. | ||
****Psychosocial factors- anxiety and depression lead to alteration of the central processing of afferents | ****Psychosocial factors- anxiety and depression lead to alteration of the central processing of afferents | ||
Revision as of 19:41, 20 October 2017
|
Irritable bowel syndrome Microchapters |
|
Differentiating Irritable bowel syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Irritable bowel syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Irritable bowel syndrome pathophysiology |
|
Risk calculators and risk factors for Irritable bowel syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Pathogenesis
- The exact pathogenesis of Irritable Bowel Syndrome (IBS) is uncertain.
- It is thought that IBS is caused by the interaction of various factors:
- Gastrointestinal motor abnormalities- IBS is referred to as ‘spastic colon’ due to changes in colonic motor function. Manometry recordings in studies from the transverse, descending and sigmoid colon showed that spastic colon led to changed patterns of colonic and small intestinal motor function such as increased frequency and irregularity of luminal contractions[1][2][3]. Peak amplitude of high-amplitude propagating contractions (HAPCs)[4] in diarrhea-prone IBS patients[5] were found to be higher, compared to healthy subjects. This led to increased responses to ingestion, CRH(Corticotropin releasing hormone)[6][7], CCK(cholecystokinin)[8] and were associated with abdominal discomfort and accelerated transit through the colon. On the other hand, constipation prone IBS patients[5] showed fewer HAPCs, delayed transit through the colon and decreased motility. One study showed that >90% of HAPCs[8] were associated with abdominal pain.
- CNS dysregulation- The conceptualization of IBS being a brain gut disorder is reinforced by the following-
1) Epidemiological studies that suggest that it occurs in individuals who have experienced childhood trauma with symptom exacerbation occurring in patients with emotional disturbances or stress. Traumatic experiences before the age of 18 can directly shape adult connectivity in the executive control network. The effects on structures such as the insula, anterior cingulate cortex and the thalamus have been implicated in the pathophysiology of central pain amplification. IBS has been found to have a high association with pre-existing psychiatric and psychological conditions like anxiety and depression. However, studies have shown that even when patients are not anxious or depressed, the dorsolateral prefrontal cortex activity was reduced, suggesting CNS dysfunction and increased susceptibility to stressors.
2) Psychological therapies that act on cerebral cortical sites and antidepressants have proven to be one of the mainstays of therapy for patients. For example, the fact that probiotics can modify signal processing in the brain also supports this theory.
3) Studies using advanced brain imaging techniques have analysed differences in brain activity between patients and healthy controls and have helped us appreciate that the mid-cingulate cortex- responsible for attention processes and responses and the prefrontal cortex-responsible for vigilance and alertness of the human brain could be involved in IBS. Modulation of the mid-cingulate cortex is associated with alterations in the subjective sensations of pain whereas prefrontal cortex modulation may lead to increased perception of visceral pain. Patients with IBS have been found to have aberrant processing of central information, with decreased feedback on the emotional arousal network that controls the autonomic modulation of gastrointenstinal function. These have been seen as irregularities on diffusion tensor imaging in the white matter of the brain. Rectal balloon distension in patients have shown increased involvement of regions of the brain associated with attentional and behavioural responses to the arrival of such stimuli.
- Psychosocial factors- anxiety and depression lead to alteration of the central processing of afferents
- Visceral hypersensitivity- Both central and peripheral mechanisms are implicated.
- Immune activation and mucosal inflammation
- Altered gut microbiota
- Gastrointestinal infections- leads to post inflammatory neuroplastic changes and visceral hypersensitivity
- Abnormal serotonin pathways
- Neuroimmune factors
- Genetic factors- Mutations in SCN5A encode alpha subunit of voltage gated sodium channel NaV1.5
- Bile acid malabsorption- causes alteration of the function of an apical ileal bile acid transporter
Genetics
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H (1996). "Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome". Scand. J. Gastroenterol. 31 (6): 581–9. PMID 8789897.
- ↑ Kumar D, Wingate DL (1985). "The irritable bowel syndrome: a paroxysmal motor disorder". Lancet. 2 (8462): 973–7. PMID 2865504.
- ↑ Simrén M, Castedal M, Svedlund J, Abrahamsson H, Björnsson E (2000). "Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]". Dig. Dis. Sci. 45 (11): 2151–61. PMID 11215731.
- ↑ Kellow JE, Phillips SF (1987). "Altered small bowel motility in irritable bowel syndrome is correlated with symptoms". Gastroenterology. 92 (6): 1885–93. PMID 3569764.
- ↑ 5.0 5.1 Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR (2008). "Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome". Clin. Gastroenterol. Hepatol. 6 (7): 772–81. doi:10.1016/j.cgh.2008.02.060. PMC 2495078. PMID 18456567.
- ↑ Whitehead WE, Engel BT, Schuster MM (1980). "Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients". Dig. Dis. Sci. 25 (6): 404–13. PMID 7379673.
- ↑ Fukudo S, Nomura T, Hongo M (1998). "Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome". Gut. 42 (6): 845–9. PMC 1727153. PMID 9691924.
- ↑ 8.0 8.1 Chey WY, Jin HO, Lee MH, Sun SW, Lee KY (2001). "Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea". Am. J. Gastroenterol. 96 (5): 1499–506. doi:10.1111/j.1572-0241.2001.03804.x. PMID 11374689.